SAN FRANCISCO, Jan. 9, 2020 — OBI Pharma, Inc., a Taiwan biopharma company (TPEx: 4174), announced that Michael Chang, Ph.D. Chairman and CEO, will present a company overview at the 38th Annual J.P. Morgan Healthcare Conference on Wednesday, …
2020-01-09
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies.